Needham & Company Maintains a 'Buy' on Vertex (VRTX); Adjusting Q2 Lower, But Positive on Cash Flow
Go back to Needham & Company Maintains a 'Buy' on Vertex (VRTX); Adjusting Q2 Lower, But Positive on Cash Flow| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 484.83 +6.13 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $478.70 | 52 Week High | $134.71 | |||
| Open | $487.52 | 52 Week Low | $73.31 | |||
| Day High | $491.95 | P/E | N/A | |||
| Day Low | $479.02 | EPS | $-1.98 | |||
| Volume | 1,382,902 | |||||
